Business Acquisition [Axis] Business Acquisition [Axis] Issuance of shares for intangible assets Noncash or Part Noncash Acquisition, Intangible Assets Acquired Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Total lease payments Lessee, Operating Lease, Liability, to be Paid Net loss Net (loss) income Net loss Net income Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Related Party Transactions [Abstract] Variable Interest Entity, Primary Beneficiary Variable Interest Entity, Primary Beneficiary [Member] Deferred tax assets, net Deferred Income Tax Assets, Net Total debt Total debt Long-Term Debt, Gross Entity Address, Postal Zip Code Entity Address, Postal Zip Code Reserve for equity issued in litigation settlement Reserve For Equity Issued In Litigation Settlement Reserve For Equity Issued In Litigation Settlement Warrants With $3.10 Exercise Price Warrants With $3.10 Exercise Price [Member] Warrants With $3.10 Exercise Price Property, Plant and Equipment [Abstract] Notes Receivable Notes Receivable [Member] Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Class of warrant exercised (in shares) Class Of Warrant Exercised Class Of Warrant Exercised 2024 Long-Term Debt, Maturity, Year Two Gain termination of lease Gain (Loss) on Termination of Lease Business acquisition, percentage of voting interests acquired Asset Acquisition, Percentage Of Voting Interests Acquired Asset Acquisition, Percentage Of Voting Interests Acquired Debt Instrument [Axis] Debt Instrument [Axis] Effective tax rate on gross profit Effective Income Tax Rate As A Percentage Of Gross Profit Effective Income Tax Rate As A Percentage Of Gross Profit Property and equipment, gross Property, Plant and Equipment, Gross Additional transaction consideration, cash at closing Additional Transaction Consideration, Cash At Closing [Member] Additional Transaction Consideration, Cash At Closing Forfeited (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Cancelled in Period, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Cancelled in Period, Weighted Average Exercise Price Income Tax Disclosure [Abstract] Receivable [Domain] Receivable [Domain] Earn-out provisions Asset Acquisition, Consideration Transferred, Contingent Consideration Additional paid-in capital Additional Paid in Capital Beneficial conversion feature associated with conversion of preferred units upon initial public offering Stock Issued During Period, Value, Beneficial Conversion Feature Of Shares Converted Stock Issued During Period, Value, Beneficial Conversion Feature Of Shares Converted Awards issued to date (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Issued To Date Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Issued To Date Statistical Measurement [Domain] Statistical Measurement [Domain] Depreciation Depreciation Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period 2022 Warrants 2022 Warrants [Member] 2022 Warrants Cash interest Interest Expense, Debt, Excluding Amortization Working capital requirements Asset Acquisition, Working Capital Requirements, Loan Capacity Asset Acquisition, Working Capital Requirements, Loan Capacity Interest rate Debt Instrument, Interest Rate, Stated Percentage Weighted average discount rate Operating Lease, Weighted Average Discount Rate, Percent Schedule of General and Administrative Expenses Schedule Of Operating Expenses [Table Text Block] Schedule Of Operating Expenses Share-Based Payment Arrangement [Abstract] Restricted common unit, par value (in dollars per share) Restricted Stock, No Par Value Restricted Stock, No Par Value Conversion of convertible notes upon initial public offering Stock Issued During Period, Value, Conversion of Convertible Securities Number of licenses acquired Number Of Intangible Assets Acquired Number Of Intangible Assets Acquired Number of Warrants Class of Warrant or Right [Roll Forward] Class of Warrant or Right Weighted average warrants granted exercise price (in dollars per share) Class of Warrant or Right, Weighted Average Warrants Granted Exercise Price Class of Warrant or Right, Weighted Average Warrants Granted Exercise Price Income taxes paid Income Taxes Paid MedMen NY Promissory Note MedMen NY Promissory Note [Member] MedMen NY Promissory Note Other current liabilities Increase (Decrease) in Other Current Liabilities Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Anti-dilutive units excluded from the calculation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Schedule of Maturities of Debt Schedule of Maturities of Long-Term Debt [Table Text Block] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Equity Component [Domain] Equity Component [Domain] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Scenario [Axis] Scenario [Axis] Acquired Finite-Lived Intangible Assets [Line Items] Acquired Finite-Lived Intangible Assets [Line Items] Ownership [Axis] Ownership [Axis] Wholesale revenue Wholesale [Member] Wholesale Investment, Name [Domain] Investment, Name [Domain] Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] LEASES Lessee, Operating Leases [Text Block] Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Fair Value of Financial Instruments Fair Value Measurement, Policy [Policy Text Block] Plan Name [Axis] Plan Name [Axis] Warrants With $3.10 Exercise Price Warrants With $6.50 Exercise Price [Member] Warrants With $6.50 Exercise Price Schedule of Unvested Restricted Stock Units Roll Forward Schedule of Unvested Restricted Stock Units Roll Forward [Table Text Block] Commercial property sale agreement price Sale Leaseback Transaction, Expected Purchase Price Sale Leaseback Transaction, Expected Purchase Price Supplemental Cash Flow Information Supplemental Cash Flow Information [Abstract] Number of consecutive quarters used for covenant measurement Debt Instrument, Number Of Consecutive Quarters Used For Covenant Measurement Debt Instrument, Number Of Consecutive Quarters Used For Covenant Measurement Number of operating segments Number of Operating Segments Plan Name [Domain] Plan Name [Domain] Remainder of 2022 Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Noncurrent liabilities Liabilities, Noncurrent Statement of Cash Flows [Abstract] Entity Address, State or Province Entity Address, State or Province Number of acquired entitles associated with sellers notes repaid Number Of Acquired Entitles Associated With Sellers Notes Repaid Number Of Acquired Entitles Associated With Sellers Notes Repaid 2025 Financing Liability, To Be Paid, Year Three Financing Liability, To Be Paid, Year Three Employee Stock Purchase Plan Employee Stock [Member] Weighted average remaining contractual term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Award Type [Axis] Award Type [Axis] Accretion Amortization Of Debt Discount And Non-Cash Interest Expense Amortization Of Debt Discount And Non-Cash Interest Expense Forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Cancelled in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Cancelled in Period Beneficial conversion feature associated with conversion of preferred units upon initial public offering Convertible Preferred Stock, Beneficial Conversion Feature Convertible Preferred Stock, Beneficial Conversion Feature Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Operating lease liabilities, current Operating Lease, Liability, Current Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Shares issued in acquisitions or asset purchases Stock Issued During Period, Value, Purchase of Assets Revenue, net Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual Entity Listings [Line Items] Entity Listings [Line Items] Thereafter Lessee, Operating Lease, Liability, To Be Paid, After Year Four Lessee, Operating Lease, Liability, To Be Paid, After Year Four Receivables [Abstract] Other Commitments [Domain] Other Commitments [Domain] Restricted Stock Awards Restricted Stock Awards [Member] Restricted Stock Awards Long-term debt, net Long-term debt, net Long-Term Debt, Excluding Current Maturities Common Units Converted Common Units Converted [Member] Common Units Converted NOTES RECEIVABLE Loans, Notes, Trade and Other Receivables Disclosure [Text Block] Total liabilities Liabilities Weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Assets acquired and liabilities assumed, current liabilities, other payable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other Payable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other Payable Proceeds from sale of assets Proceeds from Sale of Productive Assets Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Geographical [Axis] Geographical [Axis] Adjustments to purchase price allocation Goodwill, Purchase Accounting Adjustments Cash flows from investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] Issuance of common stock in public offerings, net of underwriting commissions and discounts and offering expenses Stock Issued During Period, Value, New Issues Extension term Debt Instrument, Extension Term Debt Instrument, Extension Term Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Schedule of Property and Equipment Property, Plant and Equipment [Table Text Block] Capitalized to inventory Inventories [Member] Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Document Type Document Type Weighted-Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Stock Conversion Description [Axis] Stock Conversion Description [Axis] Inventory, equity-based compensation cost Inventory, Capitalized Equity Compensation Cost Inventory, Capitalized Share-Based Compensation Cost Amortization expense capitalized to inventory during the period Capitalized Intangible Asset Amortization Capitalized Intangible Asset Amortization Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Beginning balance (in dollars per share) Ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value DEBT Debt Disclosure [Text Block] Historical LLC Units Member Units [Member] Conversion of historical common and preferred units Stock Issued During Period, Value, Conversion of Units Asset Acquisition [Axis] Asset Acquisition [Axis] Product and Service [Domain] Product and Service [Domain] Series Seed+ Preferred Units Converted Series Seed Plus Preferred Units Converted [Member] Series Seed Plus Preferred Units Converted Entity Shell Company Entity Shell Company Class B common stock Common Class B [Member] Deferred income taxes Deferred Income Tax Expense (Benefit) Beneficial conversion feature associated with conversion of preferred units upon initial public offering (in shares) Stock Issued During Period, Shares, Beneficial Conversion Feature Of Shares Converted Stock Issued During Period, Shares, Beneficial Conversion Feature Of Shares Converted Clinical funding commitment, initial commitment Clinical Funding Commitment, Initial Commitment Clinical Funding Commitment, Initial Commitment Ohio Patient Access LLC (“OPA”) Ohio Patient Access LLC (“OPA”) [Member] Ohio Patient Access LLC (“OPA”) Investments in notes receivable Payments to Acquire Notes Receivable 2023 Lessee, Operating Lease, Liability, to be Paid, Year One 2025 Long-Term Debt, Maturity, Year Three Subsequent Event Subsequent Event [Member] Marketing Marketing Expense Consolidation Items [Domain] Consolidation Items [Domain] Document Period End Date Document Period End Date Weighted-Average Remaining Exercise Period (years) Class Of Warrant Or Right, Weighted Average Remaining Exercise Period Class Of Warrant Or Right, Weighted Average Remaining Exercise Period Release of reserve for equity issued in litigation settlement Release Of Reserve For Equity Issued In Litigation Settlement Release Of Reserve For Equity Issued In Litigation Settlement Schedule of Asset Acquisition Asset Acquisition [Table Text Block] TOTAL ASSETS Assets Debt Disclosure [Abstract] Granted (in shares) Class of Warrant or Right, Granted Class of Warrant or Right, Granted Income Statement Location [Axis] Income Statement Location [Axis] MedMen NY, Inc. MedMen NY, Inc. [Member] MedMen NY, Inc. Schedule of Accounts Payable and Accrued Liabilities Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Notes receivable interest rate Notes Receivable, Interest Rate, Percent Notes Receivable, Interest Rate, Percent Current portion of debt, net Current portion of debt, net Long-Term Debt, Current Maturities Furniture, fixtures, and equipment Furniture, Fixtures, And Equipment [Member] Furniture, Fixtures, And Equipment Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Total Interest Expense, Debt Sellers' Notes Sellers' notes Sellers Notes [Member] Sellers Notes Accrued payroll and related expenses Employee-related Liabilities, Current Other Commitments [Axis] Other Commitments [Axis] Note receivable, amount issued Financing Receivable, before Allowance for Credit Loss Loss before income taxes Loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Stock conversion ratio Common Stock, Convertible, Conversion Ratio Common Stock, Convertible, Conversion Ratio Percentage of convertible noteholders that approved amendment of terms Percentage Of Convertible Noteholders That Approved Amendment Of Terms Percentage Of Convertible Noteholders That Approved Amendment Of Terms Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Tenant improvement allowance Incentive to Lessee Additional transaction consideration Additional Transaction Consideration [Member] Additional Transaction Consideration Working capital line of credit, maximum borrowing amount if amended Financing Receivable, Maximum Working Capital Line Amount If Amended Financing Receivable, Maximum Working Capital Line Amount If Amended Lease liabilities Increase in lease liability Increase (Decrease) in Operating Lease Liability Award Type [Domain] Award Type [Domain] Number of warrants (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Equity-based compensation expense, cost not yet recognized, period for recognition Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Loss on extinguishment of debt Loss on extinguishment of debt Gain (Loss) on Extinguishment of Debt Working capital line of credit, maximum borrowing amount Financing Receivable, Maximum Borrowings, Amount Financing Receivable, Maximum Borrowings, Amount Change in estimate Shares Granted, Value, Share-based Payment Arrangement, Change In Estimate Shares Granted, Value, Share-based Payment Arrangement, Change In Estimate Exercisable, weighted average remaining contractual term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Schedule of Finite-Lived Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Loss on extinguishment of debt, before write off of debt issuance cost Gain (Loss) on Extinguishment of Debt, before Write off of Debt Issuance Cost Construction deposits Construction Deposits, Current Construction Deposits, Current Gross profit Gross profit Gross Profit Other Other [Member] Other Entity Registrant Name Entity Registrant Name Issuance of common stock in public offerings, net of underwriting commissions and discounts and offering expenses (in shares) Stock Issued During Period, Shares, New Issues Real Estate Preferred Units Converted Real Estate Preferred Units Converted [Member] Real Estate Preferred Units Converted SUBSEQUENT EVENTS Subsequent Events [Text Block] Warrants with $4.00 exercise price Warrants With $4.00 Exercise Price [Member] Warrants With $4.00 Exercise Price Dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Long-term debt Long Term Debt, Excluding Current Maturities, Gross Long Term Debt, Excluding Current Maturities, Gross Marichron Pharma LLC Marichron Pharma LLC [Member] Marichron Pharma LLC Entity Address, City or Town Entity Address, City or Town Leases [Abstract] Operating expenses Operating Expenses [Abstract] Beginning balance Ending balance Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Intersegment Eliminations Intersegment Eliminations [Member] Principles of Consolidation Consolidation, Policy [Policy Text Block] Schedule of Supplemental Cash and Non-Cash Information for Leases Lessee, Leases, Additional Cash Flow Disclosures [Table Text Block] Lessee, Leases, Additional Cash Flow Disclosures Original transaction consideration, cash at closing Original Transaction Consideration, Cash At Closing [Member] Original Transaction Consideration, Cash At Closing Minimum Minimum [Member] Statement of Financial Position [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Rent and utilities Occupancy, Net Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Stock conversion, beneficial conversion feature charge Stock Conversion, Beneficial Conversion Feature Stock Conversion, Beneficial Conversion Feature Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Investment, Name [Axis] Investment, Name [Axis] Weighted average warrants expired exercise price (in dollars per share) Class of Warrant or Right, Weighted Average Warrants Expired Exercise Price Class of Warrant or Right, Weighted Average Warrants Expired Exercise Price Share price (in dollars per share) Share Price Entity File Number Entity File Number Inventory, depreciation costs Inventory, Capitalized Depreciation Inventory, Capitalized Depreciation Accrued interest Interest Payable, Current Illinois License Definitive Agreements Illinois License Definitive Agreements [Member] Illinois License Definitive Agreements Repurchase of warrants Adjustments To Additional Paid In Capital, Warrants Repurchased Adjustments To Additional Paid In Capital, Warrants Repurchased Entity Listings [Table] Entity Listings [Table] VARIABLE INTEREST ENTITIES Variable Interest Entity Disclosure [Text Block] Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] Effective tax rate Effective Income Tax Rate Reconciliation, Percent Use of Estimates Use of Estimates, Policy [Policy Text Block] Number of properties sold Number of Properties Sold Number of Properties Sold ACQUISITIONS Business Combination Disclosure [Text Block] In-place leases Leases, Acquired-in-Place [Member] Stock Options Equity Option [Member] BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] Schedule of Variable Interest Entities [Table] Schedule of Variable Interest Entities [Table] Subsequent Events [Abstract] Subsequent Events [Abstract] Revenue, net Total revenue, net Revenues Accounts payable and accrued liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities INCOME TAXES Income Tax Disclosure [Text Block] Schedule of Financing Liability, Maturity Schedule Financing Liability, Fiscal Year Maturity [Table Text Block] Financing Liability, Fiscal Year Maturity Outstanding aggregate intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding Finished goods Inventory, Finished Goods, Net of Reserves Amortization expense Amortization of Intangible Assets Exercise price of warrants, beginning (in dollars per share) Exercise price of warrants, ending (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Schedule of Goodwill Schedule of Goodwill [Table Text Block] Depreciation capitalized during the period Inventory, Depreciation Capitalized During The Period Inventory, Depreciation Capitalized During The Period Interest paid Interest Paid, Excluding Capitalized Interest, Operating Activities Net loss per share attributable to Class A and Class B stockholders of Ascend Wellness Holdings, Inc. — basic (in dollars per share) Earnings Per Share, Basic 2025 Lessee, Operating Lease, Liability, to be Paid, Year Three Number of votes per common share Common Stock, Number Of Votes Attributable To Each Share Common Stock, Number Of Votes Attributable To Each Share Noncontrolling Interest Acquired Noncontrolling Interest Acquired [Member] Noncontrolling Interest Acquired Counterparty Name [Domain] Counterparty Name [Domain] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Tenant improvement allowance Tenant Improvement Allowance, Current Tenant Improvement Allowance, Current Total stockholders' equity Equity Stockholders' Equity Attributable to Parent Prepaid expenses Prepaid Expense, Current BCCO BCCO, LLC [Member] BCCO, LLC Forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Transaction costs Asset Acquisition, Consideration Transferred, Transaction Cost Ownership [Domain] Ownership [Domain] Notes and working capital receivables Financing Receivable, after Allowance for Credit Loss Schedule of Stock Options Roll Forward Schedule of Stock Options Roll Forward [Table Text Block] 2019 AWH Convertible Notes 2019 AWH Convertible Notes [Member] 2019 AWH Convertible Notes Entity Interactive Data Current Entity Interactive Data Current Shares issued and sold (in shares) Sale of Stock, Number of Shares Issued in Transaction Accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Changes in operating assets and liabilities, net of effects of acquisitions Increase (Decrease) in Operating Capital [Abstract] Accumulated Deficit Retained Earnings [Member] Class A and Class B Common Stock Common Stock [Member] Schedule of Share-based Compensation Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Receivable Type [Axis] Receivable Type [Axis] Vesting of equity-based payment awards Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Schedule of Lease Cost Lease, Cost [Table Text Block] Number of reportable segments Number of Reportable Segments Acquisition liabilities Acquisition Liabilities, Current Acquisition Liabilities, Current Shares of stock reserved for issuance under equity incentive plan (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Class of Stock [Axis] Class of Stock [Axis] Statement [Table] Statement [Table] Weighted-Average Exercise Price Class of Warrant or Right, Exercise Price [Roll Forward] Class of Warrant or Right, Exercise Price Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Debt Instrument, Covenant Period [Axis] Debt Instrument, Covenant Period [Axis] Debt Instrument, Covenant Period Document Quarterly Report Document Quarterly Report Member units, conversion ratio Member Units, Conversion Ratio Member Units, Conversion Ratio Current assets Assets, Current [Abstract] Lease liabilities Operating Lease, Liability [Abstract] Warrants issued with notes payable Warrants Issued During Issuance Of Notes Payable Warrants Issued During Issuance Of Notes Payable Operating lease liabilities, noncurrent Operating Lease, Liability, Noncurrent Statistical Measurement [Axis] Statistical Measurement [Axis] Promissory note receivable, current Nontrade Receivables, Current Asset Acquisition [Domain] Asset Acquisition [Domain] SUPPLEMENTAL INFORMATION Additional Financial Information Disclosure [Text Block] Supply agreement, percentage of gross monthly sales after initial term Supply Agreement, Percentage Of Gross Monthly Sales For Initial Term Supply Agreement, Percentage Of Gross Monthly Sales For Initial Term Leasehold improvements Leasehold Improvements [Member] Line of credit facility, additional borrowing capacity if amended Line Of Credit Facility, Additional Borrowing Capacity If Amended Line Of Credit Facility, Additional Borrowing Capacity If Amended Accumulated deficit Retained Earnings (Accumulated Deficit) Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Equity Components [Axis] Equity Components [Axis] Scenario [Domain] Scenario [Domain] RELATED PARTY TRANSACTIONS Related Party Transactions Disclosure [Text Block] Exercisable (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Schedule of Business Acquisition, Pro Forma Information Business Acquisition, Pro Forma Information [Table Text Block] Asset acquisition, number of assets to be acquired Asset Acquisition, Number Of Assets To Be Acquired Asset Acquisition, Number Of Assets To Be Acquired Document Fiscal Year Focus Document Fiscal Year Focus Cash flows from operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] Statement [Line Items] Statement [Line Items] Beginning balance (in shares) Ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Financing costs incurred but not yet paid Financing Costs Incurred But Not Yet Paid Financing Costs Incurred But Not Yet Paid 2021 Plan 2021 Incentive Plan [Member] 2021 Incentive Plan Clinical funding commitment, amount funded Clinical Funding Commitment, Amount Funded Clinical Funding Commitment, Amount Funded Total other expense Nonoperating Income (Expense) Finite-lived intangible assets Finite-Lived Intangible Assets, Gross Loss Contingencies [Table] Loss Contingencies [Table] Capitalized lease costs Inventory, Lease Costs Capitalized Inventory, Lease Costs Capitalized stock issued during period, value, litigation settlement Stock Issued During Period, Value, Litigation Settlement Stock Issued During Period, Value, Litigation Settlement Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Cash consideration Payments to Acquire Productive Assets Total short-term and variable lease costs Short-Term Lease And Variable Lease, Cost Short-Term Lease And Variable Lease, Cost Document Transition Report Document Transition Report Local Phone Number Local Phone Number Conversion of convertible notes and accrued interest upon initial public offering Debt Conversion, Converted Instrument, Amount Operating (loss) profit Operating Income (Loss) Inventory Increase (Decrease) in Inventories Recently Adopted and Recently Issued Accounting Standards New Accounting Pronouncements, Policy [Policy Text Block] Shares issued upon conversion of convertible notes (in shares) Debt Conversion, Converted Instrument, Shares Issued Notes receivable Financing Receivable, before Allowance for Credit Loss, Current Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Goodwill Balance, December 31, 2021 Balance, June 30, 2022 Goodwill Covenant, minimum liquidity at fiscal quarter end Debt Instrument, Covenant, Minimum Liquidity At Fiscal Quarter End Debt Instrument, Covenant, Minimum Liquidity At Fiscal Quarter End Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Less: unamortized deferred financing costs Debt Issuance Costs, Current, Net Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] INTANGIBLE ASSETS AND GOODWILL Goodwill and Intangible Assets Disclosure [Text Block] Income tax expense Income tax expense Income Tax Expense (Benefit) Geographical [Domain] Geographical [Domain] Real Estate Preferred Units, Beneficial Conversion Feature Real Estate Preferred Units, Beneficial Conversion Feature [Member] Real Estate Preferred Units, Beneficial Conversion Feature Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Deferred tax liabilities, net Deferred Income Tax Liabilities, Net Story Story Of PA CR, LLC [Member] Story Of PA CR, LLC Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share 2026 Lessee, Operating Lease, Liability, to be Paid, Year Four Income Statement [Abstract] Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Additional Paid-In Capital Additional Paid-in Capital [Member] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Document Fiscal Period Focus Document Fiscal Period Focus STOCKHOLDERS’ EQUITY Members' Equity Notes Disclosure [Text Block] 2026 Financing Liability, To Be Paid, Year Four Financing Liability, To Be Paid, Year Four Number of leased assets Sale Leaseback, Number Of Leased Assets Sale Leaseback, Number Of Leased Assets Weighted-average common shares outstanding —diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Less: accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Reduction in the total additional ROU asset Increase (Decrease) In Operating Lease, Right-Of-Use Asset Increase (Decrease) In Operating Lease, Right-Of-Use Asset Schedule of Inventory, Current Schedule of Inventory, Current [Table Text Block] Expected term (years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Loss Contingencies [Line Items] Loss Contingencies [Line Items] Number of dispensary granted with right to operate Number of Dispensaries Number of Dispensaries Deferred finance costs gross Debt Issuance Costs, Gross Cash investment Cash Investment [Member] Cash Investment Accounts payable and accrued liabilities Total Accounts Payable and Accrued Liabilities, Current Class A and Class B common stock Common Stock, Value, Issued Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Commitment Other Commitment Conversion price (in dollars per share) Debt Instrument, Convertible, Conversion Price Operating Segments Operating Segments [Member] Exercisable, intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Value of awards vested at issuance Shares Granted, Value, Share-Based Payment Arrangement, after Forfeiture Clinical funding commitment, additional commitment Clinical Funding Commitment, Additional Commitment Clinical Funding Commitment, Additional Commitment Intangible asset impairment Impairment of Intangible Assets, Finite-Lived Promissory Notes Receivable Promissory Notes Receivable [Member] Promissory Notes Receivable Variable Interest Entity [Line Items] Variable Interest Entity [Line Items] Cash, cash equivalents, and restricted cash at beginning of period Cash, cash equivalents, and restricted cash at end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Prepaid deposit Prepaid Deposit [Member] Prepaid Deposit COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Issuance of warrants Adjustments to Additional Paid in Capital, Warrant Issued Clinical funding commitment, additional commitment payable Clinical Funding Commitment, Additional Commitment payable Clinical Funding Commitment, Additional Commitment payable Current liabilities Liabilities, Current [Abstract] Schedule of Interest Expense Debt, Interest Expense [Table Text Block] Debt, Interest Expense Proceeds from issuance of debt Proceeds from Issuance of Long-Term Debt Common stock shares issued (in shares) Common Stock, Shares, Issued Customer loyalty program liability Contract with Customer, Liability, Current Capital expenditures incurred but not yet paid Capital Expenditures Incurred but Not yet Paid Income Statement Location [Domain] Income Statement Location [Domain] Geisinger funding commitment Assets Acquisition, Funding Commitment, Net Assets Acquisition, Funding Commitment, Net Amendment Flag Amendment Flag Acquisition, number of locations to be opened Asset Acquisition, Number Of Locations To Be Opened Asset Acquisition, Number Of Locations To Be Opened Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Professional services Professional Fees Operating lease costs Operating Lease, Cost Shareholder Litigation Matter Shareholder Litigation Matter [Member] Shareholder Litigation Matter Debt instrument, amount Debt Instrument, Face Amount New York And Pennsylvania Properties New York And Pennsylvania Properties [Member] New York And Pennsylvania Properties 2021 Credit Facility 2021 Credit Facility [Member] 2021 Credit Facility Thereafter Financing Liability, To Be Paid, After Year Four Financing Liability, To Be Paid, After Year Four Insurance General Insurance Expense Historical preferred units Preferred Units [Member] Preferred Units Construction in progress Construction in Progress [Member] Assets acquired and liabilities , current liabilities, other paid Business Combination, Recognized Identifiable Assets Acquired and Liabilities , Current Liabilities, Other Paid Business Combination, Recognized Identifiable Assets Acquired and Liabilities , Current Liabilities, Other Paid Cost of initial investment Asset Acquisition Cost of Initial Investment Asset Acquisition Cost of Initial Investment Entity Current Reporting Status Entity Current Reporting Status Goodwill and Intangible Assets Disclosure [Abstract] Other current liabilities Other Liabilities, Current Income taxes payable Increase (Decrease) in Accrued Taxes Payable Other noncurrent assets Other Assets, Noncurrent Reimbursement of equipment purchase Reimbursement of Equipment Purchase Reimbursement of Equipment Purchase Capitalized compensation costs included in inventory Other Inventory, Capitalized Costs, Gross Exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Stock Options Additional Disclosures Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Depreciation and amortization Depreciation, Depletion and Amortization Repayments of notes payable Repayments of Notes Payable Finance liabilities Finance Liabilities [Member] Finance Liabilities Operating lease term Lessee, Operating Lease, Term of Contract Counterparty Name [Axis] Counterparty Name [Axis] Accumulated depreciation written off Accumulated Depreciation, Depletion and Amortization, Sale or Disposal of Property, Plant and Equipment Equity-based compensation costs capitalized during the period Share-based Payment Arrangement, Expense Capitalized During The Period Share-based Payment Arrangement, Expense Capitalized During The Period Outstanding beginning balance (in shares) Outstanding ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Term notes Term Loans [Member] Term Loans Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Litigation settlement Estimated Litigation Liability, Current IPO IPO [Member] Stock and warrants issued during period, value, preferred stock and warrants Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Number of financial covenants Debt Instrument, Number Of Financial Covenants Debt Instrument, Number Of Financial Covenants Number of Shares (in thousands) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Property and equipment, net Property and equipment, net Property, Plant and Equipment, Net Compensation Labor and Related Expense Operating cash flows from operating leases Operating Lease, Payments Repayments of debt Repayments of Long-Term Debt Increase in tenant improvement allowance Increase (Decrease) In Incentive To Lessee Increase (Decrease) In Incentive To Lessee Other noncurrent assets Increase (Decrease) in Other Noncurrent Assets Direct issuance costs incurred but not yet paid Stock Issuance Costs Incurred But Not Yet Paid Stock Issuance Costs Incurred But Not Yet Paid Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Non-cash interest related to beneficial conversion feature Interest Expense, Beneficial Conversion Feature, Non-Cash Interest Expense, Beneficial Conversion Feature, Non-Cash Hemma Hemma LLC [Member] Hemma LLC Sellers Note, Noncontrolling Interest Sellers Note, Noncontrolling Interest [Member] Sellers Note, Noncontrolling Interest Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Long-term debt, net Long-term debt, net Long-Term Debt Other, net Other Nonoperating Income (Expense) Balance Sheet Location [Axis] Balance Sheet Location [Axis] Shares issued and sold, price per share (in dollars per share) Sale of Stock, Price Per Share Common stock, shares authorized (in shares) Common Stock, Shares Authorized Income taxes payable Accrued Income Taxes, Current Aggregate intrinsic value Class Of Warrant Or Right, Intrinsic Value, Exercise Price Of Warrants Or Rights Class Of Warrant Or Right, Intrinsic Value, Exercise Price Of Warrants Or Rights Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Total operating expenses Operating Expenses Maximum Maximum [Member] Class A common stock Common Class A [Member] Equity-based compensation expense (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture New York NEW YORK Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Cash and Cash Equivalents and Restricted Cash Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Expired (in shares) Class of Warrant or Right, Expired Class of Warrant or Right, Expired Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Total current assets Current assets Assets, Current Athol, Massachusetts and Lansing, Michigan Athol, Massachusetts And Lansing, Michigan [Member] Athol, Massachusetts And Lansing, Michigan Business Acquisition [Line Items] Business Acquisition [Line Items] Entity Small Business Entity Small Business Schedule Warrants Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Interest on financing liability Interest On Financing Liability Interest On Financing Liability Beginning balance (in shares) Ending balance (in shares) Common stock shares outstanding (in shares) Shares, Outstanding Current portion of debt Long Term Debt, Current Maturities, Gross Long Term Debt, Current Maturities, Gross Acquisition, consideration, number of shares issued, value Equity consideration Asset Acquisition, Consideration Transferred, Equity Interest Issued and Issuable Amortization of operating lease assets Operating Lease, Right-of-Use Asset, Amortization Expense Intangible assets, net Total intangible assets, net Finite-Lived Intangible Assets, Net Grant date fair value per warrant (in dollars per share) Class of Warrant or Right, Grant Date Fair Value Per Warrant Class of Warrant or Right, Grant Date Fair Value Per Warrant Equity-based compensation expense, cost not yet recognized Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Deposits and other receivables Deposits Assets, Current Number of Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] PROPERTY AND EQUIPMENT Property, Plant and Equipment Disclosure [Text Block] Non-cash interest expense Paid-in-Kind Interest Inventory, capitalized amortization Inventory, Capitalized Intangible Asset Amortization Inventory, Capitalized Intangible Asset Amortization Warrants issuance first anniversary Warrants Issuance First Anniversary Warrants Issuance First Anniversary Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Accounts receivable Increase (Decrease) in Accounts Receivable Consolidated Entities [Axis] Consolidated Entities [Axis] Shares issued in conversion (in shares) Conversion of Stock, Shares Issued Asset acquisition, price of acquisition, expected Asset Acquisition, Price of Acquisition, Expected Subsequent Event [Line Items] Subsequent Event [Line Items] Lease assets Operating Lease Right-Of-Use Asset [Abstract] Operating Lease Right-Of-Use Asset Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Conversion of preferred units into Class A common stock upon initial public offering Conversion of Stock, Amount Converted Debt Instrument [Line Items] Debt Instrument [Line Items] Business Combination and Asset Acquisition [Abstract] Class of Warrant or Right [Table] Class of Warrant or Right [Table] Class of Stock [Line Items] Class of Stock [Line Items] Vesting of equity-based payment awards (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Debt issuance costs Payments of Debt Issuance Costs Present value of lease liabilities Total lease liabilities Operating Lease, Liability REPORTABLE SEGMENTS AND REVENUE Segment Reporting Disclosure [Text Block] Repurchase of warrants Payments for Repurchase of Warrants Liabilities and Stockholders' Equity Liabilities and Equity [Abstract] Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Debt Instrument, Covenant Period [Domain] Debt Instrument, Covenant Period [Domain] Debt Instrument, Covenant Period [Domain] Segment Reporting, Revenue Reconciling Item [Line Items] Segment Reporting, Revenue Reconciling Item [Line Items] Purchase of intangible assets Purchase of intangible assets Payments to Acquire Intangible Assets Shares issued in acquisitions or asset purchases (in shares) Stock Issued During Period, Shares, Purchase of Assets Settlement amount Litigation Settlement, Amount Awarded to Other Party Clinical funding commitment, additional commitment term Clinical Funding Commitment, Additional Commitment Term Clinical Funding Commitment, Additional Commitment Term Remainder of 2022 Long-Term Debt, Maturity, Remainder of Fiscal Year Grant date fair value of warrants Class of Warrant or Right, Estimated Grant Date Fair Value Class of Warrant or Right, Estimated Grant Date Fair Value Shares issued and sold, net proceeds Sale of Stock, Consideration Received on Transaction Inventory Total Inventory, Net Accounts payable Accounts Payable, Current Clinical funding commitment, initial commitment term Clinical Funding Commitment, Initial Commitment Term Clinical Funding Commitment, Initial Commitment Term 2026 Long-Term Debt, Maturity, Year Four Total Financing Liability Financing Liability Loss on extinguishment of debt, write-off of unamortized deferred financing costs Write off of Deferred Debt Issuance Cost THE COMPANY AND NATURE OF OPERATIONS Nature of Operations [Text Block] Entity Filer Category Entity Filer Category Weighted-average common shares outstanding — basic (in shares) Weighted Average Number of Shares Outstanding, Basic Stockholders' Equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Schedule of Variable Interest Entities Schedule of Variable Interest Entities [Table Text Block] Net loss Net (loss) income Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual 2020 Plan 2020 Incentive Plan [Member] 2020 Incentive Plan Capital expenditure allowance (up to) Lessee, Capital Expenditure Allowance Lessee, Capital Expenditure Allowance Purchase price Total Acquisition consideration Asset Acquisition, Consideration Transferred Equity-based compensation expense Share-Based Payment Arrangement, Expense Commitments and contingencies (Note 15) Commitments and Contingencies Outstanding beginning balance (in dollars per share) Outstanding ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Licenses and permits License [Member] Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Loss on sale of assets (Gain) loss on sale of assets Gain (Loss) on Disposition of Assets 2022 Loan 2022 Loan [Member] 2022 Loan Preferred stock, $0.001 par value per share; 10,000 shares authorized, none issued and outstanding as of June 30, 2022 and December 31, 2021 (Note 12) Preferred Stock, Value, Issued Restricted Common Shares Restricted Stock [Member] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] General and administrative expenses General and Administrative Expense [Member] Conversion of convertible notes upon initial public offering (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Amount due upon first adult-use cannabis sale Additional Investment In Affiliate Upon First Sale [Member] Additional Investment In Affiliate Upon First Sale Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Cover [Abstract] Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction EQUITY-BASED COMPENSATION EXPENSE Share-Based Payment Arrangement [Text Block] Allowance for doubtful accounts Accounts Receivable, Allowance for Credit Loss Work in process Inventory, Work in Process, Net of Reserves Schedule of Other Current Assets Schedule of Other Current Assets [Table Text Block] Segment Reporting [Abstract] Historical LLC units, beginning balance (in shares) Historical LLC units, ending balance (in shares) Common Unit, Outstanding Forecast Forecast [Member] Number of common stock shares received for each restricted unit Share-Based Compensation Arrangement by Share-Based Payment Award, Share Conversion Ratio Share-Based Compensation Arrangement by Share-Based Payment Award, Share Conversion Ratio Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Taxes withheld under equity-based compensation plans, net Payment, Tax Withholding, Share-Based Payment Arrangement TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity Pennsylvania PENNSYLVANIA Materials and supplies Inventory, Raw Materials and Supplies, Net of Reserves Goodwill [Roll Forward] Goodwill [Roll Forward] Land Land [Member] Organization, Consolidation and Presentation of Financial Statements [Abstract] Acquisition of businesses, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Collection of notes receivable Proceeds from Collection of Notes Receivable Current Fiscal Year End Date Current Fiscal Year End Date Equity issued in litigation settlement (in shares) Stock Issued During Period, Shares, Litigation Settlement Stock Issued During Period, Shares, Litigation Settlement Franklin, New Jersey Franklin, New Jersey [Member] Franklin, New Jersey Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Net loss per share attributable to Class A and Class B stockholders of Ascend Wellness Holdings, Inc. — diluted (in dollars per share) Earnings Per Share, Diluted Sale of Stock [Domain] Sale of Stock [Domain] Proceeds from sale of capital asset Proceeds from Sale of Property, Plant, and Equipment Stock split, conversion ratio Stockholders' Equity Note, Stock Split, Conversion Ratio Conversion of historical common and preferred units (in shares) Partners' Capital Account, Units, Converted Award vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Loss on sale of property Gain (Loss) on Disposition of Property Plant Equipment Underwriting discounts Payments of Stock Issuance Costs Ownership interest percentage Noncontrolling Interest, Ownership Percentage by Parent Schedule of Common Stock Outstanding Schedule of Stock by Class [Table Text Block] Equity-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition 2024 Financing Liability, To Be Paid, Year Two Financing Liability, To Be Paid, Year Two Consolidation Items [Axis] Consolidation Items [Axis] Reconciliation of Revenue from Segments to Consolidated [Table] Reconciliation of Revenue from Segments to Consolidated [Table] Total current liabilities Current liabilities Liabilities, Current 2024 Lessee, Operating Lease, Liability, to be Paid, Year Two Other current assets Total Other Assets, Current Schedule of Notes Receivable Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Other Other General Expense 2023 Financing Liability, To Be Paid, Year One Financing Liability, To Be Paid, Year One Impairment of notes receivable Financing Receivable, Credit Loss, Expense (Reversal) Entity Ex Transition Period Entity Ex Transition Period Remainder of 2022 Financing Liability, To Be Paid, Remainder Of Fiscal Year Financing Liability, To Be Paid, Remainder Of Fiscal Year Other liabilities assumed Assets Acquisition RecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther Assets Acquisition RecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther Other (expense) income Nonoperating Income (Expense) [Abstract] Fixed asset purchases Accrued Capital Expenditures Accrued Capital Expenditures Schedule of Operating Lease, Liability Maturity Lessee, Operating Lease, Liability, Maturity [Table Text Block] Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, Address Line One Entity Address, Address Line One Cost of goods sold Cost of Revenue Period due following investment agreement termination Financing Receivable, Period Due Following Investment Agreement Termination Financing Receivable, Period Due Following Investment Agreement Termination Supply agreement, percentage of gross monthly sales after initial term Supply Agreement, Percentage Of Gross Monthly Sales After Initial Term Supply Agreement, Percentage Of Gross Monthly Sales After Initial Term Retail revenue Retail [Member] Over-Allotment Option Over-Allotment Option [Member] Product and Service [Axis] Product and Service [Axis] Conversion ratio multiplier Stock Conversion Ratio, Multiplier Stock Conversion Ratio, Multiplier Class of Stock [Domain] Class of Stock [Domain] Supply agreement, initial term Supply Agreement, Initial Term Supply Agreement, Initial Term Subsidiary, Sale of Stock [Line Items] Subsidiary, Sale of Stock [Line Items] Interest expense Interest Expense Trade names Trade Names [Member] INVENTORY Inventory Disclosure [Text Block] Working Capital Loan Working Capital Loan [Member] Working Capital Loan Equity [Abstract] Schedule of Debt Instruments Schedule of Long-Term Debt Instruments [Table Text Block] Subsequent Event [Table] Subsequent Event [Table] Buildings Building [Member] Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Inventory Disclosure [Abstract] Entity Tax Identification Number Entity Tax Identification Number Maximum number of awards to be issued (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Debt Instrument, Covenant, Period Two Debt Instrument, Covenant, Period Two [Member] Debt Instrument, Covenant, Period Two Additional debt issuance cost Additional Debt Issuance Cost Additional Debt Issuance Cost Purchase price Asset Acquisition, Consideration Transferred, Equity and Cash Consideration Asset Acquisition, Consideration Transferred, Equity and Cash Consideration Schedule Of Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Consolidated Entities [Domain] Consolidated Entities [Domain] Taxes withheld under equity-based compensation plans, net (in shares) Taxes withheld under equity-based compensation plans, net (in shares) Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation Historical Common Units Common Units [Member] Common Units Common unit, par value (in dollars per share) Common Stock, No Par Value Schedule of Effective Income Tax Rate Reconciliation Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Settlement expense Litigation Settlement, Expense Other Other Assets, Miscellaneous, Current Net (decrease) increase in cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Forgive ness of bridge loan Asset Acquisition, Consideration Transferred, Forgiveness Of Bridge Loan Asset Acquisition, Consideration Transferred, Forgiveness Of Bridge Loan Maximum borrowing capacity if amended Line Of Credit Facility, Maximum Borrowing Capacity If Amended Line Of Credit Facility, Maximum Borrowing Capacity If Amended Entity Central Index Key Entity Central Index Key Weighted-Average Grant Date Fair Value per Share Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Taxes withheld under equity-based compensation plans, net Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Conversion of historical common and preferred units (in shares) Stock Issued During Period, Shares, Conversion of Units Stock and warrants issued during period shares preferred stock and warrants ( in shares) Stock and Warrants Issued During Period Shares Preferred Stock and Warrants Stock and Warrants Issued During Period Shares Preferred Stock and Warrants Other Other Accrued Liabilities, Current Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] OCC Ohio Cannabis Clinic, LLC [Member] Ohio Cannabis Clinic, LLC City Area Code City Area Code General and administrative expenses Total General and Administrative Expense Assets Assets [Abstract] Other current assets Increase (Decrease) in Other Current Assets Number of acquired entitles associated with sellers notes outstanding Number Of Acquired Entitles Associated With Sellers Notes Outstanding Number Of Acquired Entitles Associated With Sellers Notes Outstanding Less: unamortized deferred financing costs Debt Issuance Costs, Noncurrent, Net Covenant, maximum EBITDA to cash interest expense ratio Debt Instrument, Covenant, Maximum EBITDA To Cash Interest Expense Ratio Debt Instrument, Covenant, Maximum EBITDA To Cash Interest Expense Ratio Statement of Stockholders' Equity [Abstract] Sale of Stock [Axis] Sale of Stock [Axis] Cash flows from financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Preferred unit, par value (in dollars per share) Preferred Stock, No Par Value Proceeds from issuance of common stock in public offerings, net of underwriting discounts and commissions and offering expenses Proceeds from Issuance Initial Public Offering Basic and Diluted Loss per Share Earnings Per Share, Policy [Policy Text Block] 2023 Long-Term Debt, Maturity, Year One Non-cash investing and financing activities Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Equity-based compensation expense Share-Based Payment Arrangement, Noncash Expense Equity issued in litigation settlement Equity Issued In Litigation Settlement Equity Issued In Litigation Settlement Weighted-average fair value of stock options granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Outstanding, beginning balance (in shares) Outstanding, ending balance (in shares) Class of Warrant or Right, Outstanding Other non-current liabilities Other Liabilities, Noncurrent Schedule of Components of Lease Assets and Lease Liabilities Lessee, Leases, Additional Balance Sheet Disclosures [Table Text Block] Lessee, Leases, Additional Balance Sheet Disclosures Additions to capital assets Payments to Acquire Property, Plant, and Equipment Compensation costs capitalized during the period Compensation Costs Capitalized During The Period Compensation Costs Capitalized During The Period Conversion of Stock, Name [Domain] Conversion of Stock, Name [Domain] Increase in right-of-use asset Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Cost of goods sold Cost of Sales [Member] Promissory note receivable, noncurrent Nontrade Receivables, Noncurrent Assets acquired and liabilities assumed, current liabilities, other paid 1 Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other Paid 1 Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other Paid 1 Acquisition, consideration, number of shares issued (in shares) Asset Acquisition, Equity Interest Issued or Issuable, Number of Shares Asset Acquisition, Equity Interest Issued or Issuable, Number of Shares